SCOPUS 정보 검색 플랫폼

Volumn 14, Issue 9, 2000, Pages 1577-1582

Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy

(8) Weiss, M A a Glenn, M a Maslak, P a Rahman, Z a Noy, A a Zelenetz, A a Scheinberg, D A a Golde, D W a

a WEILL CORNELL MEDICAL COLLEGE (United States)

Author keywords

CLL; Cyclophosphamide; Fludarabine; Minimal residual disease

Indexed keywords

CD19 ANTIGEN; CD5 ANTIGEN; CYCLOPHOSPHAMIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; OLIGONUCLEOTIDE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG MEGADOSE; DRUG POTENTIATION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; MALE; MINIMAL RESIDUAL DISEASE; NEUTROPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL TIME; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 0033828586 PISSN: 08876924 EISSN: None Source Type: Journal
DOI: 10.1038/sj.leu.2401892 Document Type: Article

Times cited : (41)

References (25)

1
- 0026038974
- B-cell chronic lymphocytic leukemia: Present status and future directions
- and the French Cooperative Group on CLL.
- (1991) Blood , vol.78 , pp. 1901-1914
- Dighiero, G.¹ Travade, P.² Chevret, S.³ Fenaux, P.⁴ Chastang, C.⁵ Binet, J.-L.⁶

2
- 0028931830
- Advances in the biology and treatment of B-cell chronic lymphocytic leukemia
- (1995) Blood , vol.85 , pp. 307-318
- O'Brien, S.¹ del Giglio, A.² Keating, M.³

3
- 0024216099
- Fludarabine monophosphate: A potentially useful agent in chronic lymphocytic leukemia
- (1988) Nouv Rev Fr Hematol , vol.30 , pp. 457-459
- Grever, M.R.¹ Kopecky, K.J.² Coltman, C.A.³ Files, J.C.⁴ Greenberg, B.R.⁵ Hutton, J.J.⁶ Talley, R.⁷ Von Hoff, D.D.⁸ Balcerzak, S.P.⁹

4
- 0024319910
- Fludarabine: A new agent with major activity against chronic lymphocytic leukemia
- (1989) Blood , vol.74 , pp. 19-25
- Keating, M.J.¹ Kantarjian, H.² Talpaz, M.³ Redman, J.⁴ Koller, C.⁵ Barlogie, B.⁶ Velasquez, W.⁷ Plunkett, W.⁸ Freireich, E.J.⁹ McCredie, K.B.¹⁰

5
- 0027465143
- High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: Response predicted by rapid decrease of blood lymphocyte count
- (1993) J Clin Oncol , vol.11 , pp. 679-689
- Juliusson, G.¹ Liliemark, J.²

6
- 0028945716
- 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia
- (1995) J Clin Oncol , vol.13 , pp. 570-574
- Saven, A.¹ Leman, R.H.² Kosty, M.³ Beutler, E.⁴ Piro, L.D.⁵

7
- 0021933387
- Low-dose deoxycoformycin in lymphoid malignancy
- (1985) J Clin Oncol , vol.3 , pp. 1196-1201
- Grever, M.R.¹ Leiby, J.M.² Kraut, E.H.³ Wilson, H.E.⁴ Neidhart, J.A.⁵ Wall, R.L.⁶ Balcerzak, S.P.⁷

8
- 0024551346
- Pentostatin in chronic lymphocytic leukemia: A phase II trial of cancer and leukemia Group B
- (1989) J Clin Oncol , vol.7 , pp. 433-438
- Dillman, R.O.¹ Mick, R.² Ross McIntyre, O.R.³

9
- 0026015638
- Fludarabine: A new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia
- (1991) J Clin Oncol , vol.9 , pp. 44-49
- Keating, M.J.¹ Kantarjian, H.² O'Brien, S.³ Koller, C.⁴ Talpaz, M.⁵ Schachner, J.⁶ Childs, C.C.⁷ Freireich, E.J.⁸ McCredie, K.B.⁹

10
- 0027200169
- Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent
- (1993) Blood , vol.81 , pp. 2878-2884
- Keating, M.J.¹ O'Brien, S.² Kantarjian, H.³ Plunkett, W.⁴ Estey, E.⁵ Killer, C.⁶ Beran, M.⁷ Freireich, E.J.⁸

11
- 0026645858
- Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone
- (1992) Ann Intern Med , vol.117 , pp. 466-469
- Anaissie, E.¹ Kontoyiannis, D.P.² Kantarjian, H.³ Elting, L.⁴ Robertson, L.E.⁵ Keating, M.⁶

12
- 0027323550
- Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment
- (1993) Blood , vol.82 , pp. 1695-1700
- O'Brien, S.¹ Kantarjian, H.² Beran, M.³ Smith, T.⁴ Koller, C.⁵ Estey, E.⁶ Robertson, L.E.⁷ Lerner, S.⁸ Keating, M.⁹

13
- 0027483579
- A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: A Southwest Oncology Group study
- (1993) Leukemia , vol.7 , pp. 361-365
- Elias, L.¹ Stock-Novack, D.² Head, D.R.³ Grever, M.R.⁴ Weick, J.K.⁵ Chapman, R.A.⁶ Godwin, J.E.⁷ Metz, E.N.⁸ Appelbaum, F.R.⁹

14
- 0028022841
- Concomitant administration of chlorambucil limits dose intensity of fludarabine in previously treated patients with chronic lymphocytic leukemia
- (1994) Leukemia , vol.8 , pp. 1290-1293
- Weiss, M.¹ Spiess, T.² Berman, E.³ Kempin, S.⁴

15
- 0023717101
- Guidelines for clinical protocols for chronic lymphocytic leukemia: Report of the NCI-Sponsored Working Group
- (1988) Am J Hematol , vol.29 , pp. 152-163
- Cheson, B.D.¹ Bennett, J.M.² Rai, K.R.³ Grever, M.⁴ Kay, N.⁵ Schiffer, C.⁶ Oken, M.⁷ Keating, M.⁸ Boldt, D.⁹ Kempin, S.¹⁰ Foon, K.¹¹

16
- 0024255987
- Natural history of chronic lymphocytic leukemia: On the progression and prognosis of early clinical stages
- (1988) Nouv Rev Fr Hematol , vol.30 , pp. 359-361
- Montserrat, E.¹ Vinolas, N.² Reverter, J.C.³ Rozman, C.⁴

17
- 0008068161
- Clonotypic PCR confirms minimal residual disease (MRD) in CLL nodular PR: Preliminary results from a sequential treatment CLL protocol
- (submitted)
- Blood
- Noy, A.¹ Verma, R.² Glenn, M.³ Maslak, P.⁴ Rahman, Z.⁵ Keenan, J.⁶ Weiss, M.⁷ Zelenetz, A.⁸

18
- 0008119573
- National Cancer Institute, Division of Cancer Treatment. Common Toxicity Criteria. Bethesda, MD
- (1988)

19
- 0000431595
- A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A CALGB, SWOG, CTG/NCI-C and ECOG Inter-group study
- (1996) Blood , vol.88
- Rai, K.R.¹ Peterson, B.² Elias, L.³ Shepherd, L.⁴ Hines, J.⁵ Nelson, D.⁶ Cheson, B.⁷ Kolitz, J.⁸ Schiffer, C.⁹

20
- 0003348637
- Fludarabine induces a high complete remission rate in previously untreated patients with active chronic lymphocytic leukemia. A randomized inter-group study
- (1995) Blood , vol.86
- Rai, K.R.¹ Peterson, B.² Kolitz, J.³ Elias, L.⁴ Shepherd, J.⁵ Hines, J.⁶ Cheson, B.⁷ Schiffer, C.⁸

21
- 0003258512
- Fludarabine (FAMP) and cyclophosphamide (CTX) therapy in chronic lymphocytic leukemia (CLL)
- (1996) Blood , vol.88
- O'Brien, S.¹ Kantarjian, H.² Beran, M.³ Freireich, E.⁴ Kornblau, S.⁵ Killer, C.⁶ Lerner, S.⁷ Gilbreath, J.⁸ Keating, M.⁹

22
- 0029981025
- National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment
- (1996) Blood , vol.87 , pp. 4990-4997
- Cheson, B.D.¹ Bennett, J.M.² Grever, M.³ Kay, N.⁴ Keating, M.⁵ O'Brien, S.⁶ Rai, K.⁷

23
- 0026776598
- Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: Clinical, immunophenotypic and molecular analysis
- (1992) Blood , vol.80 , pp. 29-36
- Robertson, L.E.¹ Huh, Y.O.² Butler, J.J.³ Pugh, W.⁴ Hirsch-Ginsburg, C.⁵ Stass, S.⁶ Kantarjian, H.⁷ Keating, M.⁸

24
- 15844368449
- Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia
- (1996) Lancet , vol.347 , pp. 1432-1438
- Johnson, S.¹ Smith, A.G.² Loffler, H.³ Osby, E.⁴ Juliusson, G.⁵ Emmerich, B.⁶ Wyld, P.⁷ Hiddemann, W.⁸

25
- 0344729013
- Chlorambucil in indolent chronic lymphocytic leukemia
- (1998) New Engl J Med , vol.338 , pp. 1506-1514
- Dighiero, G.¹ Maloum, K.² Desablens, B.³ Cazin, B.⁴ Navarro, M.⁵ Leblay, R.⁶ Leporier, M.⁷ Jaubert, J.⁸ Lepeu, G.⁹ Dreyfus, B.¹⁰ Binet, J.¹¹ Travade, P.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.